Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver X Receptor Alpha (LXRα), encoded by the NR1H3 gene, is a ligand-activated nuclear receptor and transcription factor belonging to the liver X receptor (LXR) family. It plays a central role in cholesterol homeostasis, lipid metabolism, and inflammation. LXRα is activated by oxysterols and synthetic agonists, forming heterodimers with retinoid X receptors (RXRs) to regulate the transcription of genes involved in cholesterol efflux, bile acid synthesis, and fatty acid metabolism. It is highly expressed in liver, adrenal gland, intestine, adipose tissue, macrophages, lung, and kidney. Pharmacological targeting has been explored for metabolic diseases like atherosclerosis and non-alcoholic fatty liver disease, as well as inflammatory conditions. It modulates immune responses and may have therapeutic potential for skin diseases such as psoriasis.
Ligand-activated transcription factor; heterodimerizes with RXR and binds to LXREs to regulate gene expression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver X Receptor Alpha (LXRα).